Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1996 Oct;89(2):301–307. doi: 10.1046/j.1365-2567.1996.d01-733.x

Stem cell factor potentiates histamine secretion by multiple mechanisms, but does not affect tumour necrosis factor-alpha release from rat mast cells.

T J Lin 1, E Y Bissonnette 1, A Hirsh 1, A D Befus 1
PMCID: PMC1456491  PMID: 8943730

Abstract

The effect of stem cell factor (SCF) on histamine and tumour necrosis factor-alpha (TNF-alpha) release from rat peritoneal mast cells (PMC) was determined and the intracellular pathways involved in the potentiation of histamine secretion were investigated. The effects of SCF (2-100 ng/ml) were examined following both short-term (0 and 20 min) and long-term (up to 24hr) preincubations with SCF. Pretreatment of PMC with SCF for 0 min (concurrent) or 20 min did not induce histamine secretion directly, but significantly increased antigen (Ag)-induced histamine secretion. SCF potentiated Ag-induced intracellular Ca2+ increase and calcium ionophore A23187-induced histamine secretion. Pertussis toxin (PT) inhibited SCF-induced potentiation of IgE-dependent histamine secretion, indicating that PT-sensitive G-proteins are involved in the immediate effects of SCF. In long-term incubation experiments, SCF pretreatment for 18-24 hr significantly enhanced Ag-induced histamine secretion, but did not affect Ag-induced intracellular Ca2+ levels. The effects of long-term incubation with SCF, but not the short-term effects, were blocked by cycloheximide. Interestingly, spontaneous and Ag-induced TNF-alpha release from rat PMC were not affected by pretreatment with SCF (2-500 ng/ml) for 1 to 24 hr. Thus, through immediate and delayed mechanisms, SCF potentiates histamine release from PMC, but has not effect on TNF-alpha release. The regulation of MC by SCF may be important in allergic and other inflammatory diseases.

Full text

PDF
301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando A., Martin T. R., Galli S. J. Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. J Clin Invest. 1993 Oct;92(4):1639–1649. doi: 10.1172/JCI116749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Befus A. D., Pearce F. L., Gauldie J., Horsewood P., Bienenstock J. Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells. J Immunol. 1982 Jun;128(6):2475–2480. [PubMed] [Google Scholar]
  3. Bischoff S. C., Dahinden C. A. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med. 1992 Jan 1;175(1):237–244. doi: 10.1084/jem.175.1.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bissonnette E. Y., Befus A. D. Inhibition of mast cell-mediated cytotoxicity by IFN-alpha/beta and -gamma. J Immunol. 1990 Nov 15;145(10):3385–3390. [PubMed] [Google Scholar]
  5. Calderón C., Huang Z. H., Gage D. A., Sotomayor E. M., Lopez D. M. Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine. J Exp Med. 1994 Sep 1;180(3):945–958. doi: 10.1084/jem.180.3.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Coleman J. W., Holliday M. R., Kimber I., Zsebo K. M., Galli S. J. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol. 1993 Jan 15;150(2):556–562. [PubMed] [Google Scholar]
  7. Columbo M., Horowitz E. M., Botana L. M., MacGlashan D. W., Jr, Bochner B. S., Gillis S., Zsebo K. M., Galli S. J., Lichtenstein L. M. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol. 1992 Jul 15;149(2):599–608. [PubMed] [Google Scholar]
  8. Dastych J., Metcalfe D. D. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol. 1994 Jan 1;152(1):213–219. [PubMed] [Google Scholar]
  9. Duronio V., Welham M. J., Abraham S., Dryden P., Schrader J. W. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1587–1591. doi: 10.1073/pnas.89.5.1587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Espevik T., Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986 Dec 4;95(1):99–105. doi: 10.1016/0022-1759(86)90322-4. [DOI] [PubMed] [Google Scholar]
  11. Galli S. J., Zsebo K. M., Geissler E. N. The kit ligand, stem cell factor. Adv Immunol. 1994;55:1–96. doi: 10.1016/s0065-2776(08)60508-8. [DOI] [PubMed] [Google Scholar]
  12. Ghosh S., Xie W. Q., Quest A. F., Mabrouk G. M., Strum J. C., Bell R. M. The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras. J Biol Chem. 1994 Apr 1;269(13):10000–10007. [PubMed] [Google Scholar]
  13. Gordon J. R., Galli S. J. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med. 1991 Jul 1;174(1):103–107. doi: 10.1084/jem.174.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  15. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol. 1989;7:59–76. doi: 10.1146/annurev.iy.07.040189.000423. [DOI] [PubMed] [Google Scholar]
  16. Langley K. E., Bennett L. G., Wypych J., Yancik S. A., Liu X. D., Westcott K. R., Chang D. G., Smith K. A., Zsebo K. M. Soluble stem cell factor in human serum. Blood. 1993 Feb 1;81(3):656–660. [PubMed] [Google Scholar]
  17. Leal-Berumen I., Conlon P., Marshall J. S. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol. 1994 Jun 1;152(11):5468–5476. [PubMed] [Google Scholar]
  18. Meininger C. J., Yano H., Rottapel R., Bernstein A., Zsebo K. M., Zetter B. R. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood. 1992 Feb 15;79(4):958–963. [PubMed] [Google Scholar]
  19. Miyazawa K., Hendrie P. C., Mantel C., Wood K., Ashman L. K., Broxmeyer H. E. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase. Exp Hematol. 1991 Dec;19(11):1110–1123. [PubMed] [Google Scholar]
  20. Murakami M., Austen K. F., Arm J. P. The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. J Exp Med. 1995 Jul 1;182(1):197–206. doi: 10.1084/jem.182.1.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nagai S., Kitani S., Hirai K., Takaishi T., Nakajima K., Kihara H., Nonomura Y., Ito K., Morita Y. Pharmacological study of stem-cell-factor-induced mast cell histamine release with kinase inhibitors. Biochem Biophys Res Commun. 1995 Mar 17;208(2):576–581. doi: 10.1006/bbrc.1995.1377. [DOI] [PubMed] [Google Scholar]
  22. Nakajima K., Hirai K., Yamaguchi M., Takaishi T., Ohta K., Morita Y., Ito K. Stem cell factor has histamine releasing activity in rat connective tissue-type mast cells. Biochem Biophys Res Commun. 1992 Mar 31;183(3):1076–1083. doi: 10.1016/s0006-291x(05)80300-6. [DOI] [PubMed] [Google Scholar]
  23. Newton A. C., Keranen L. M. Phosphatidyl-L-serine is necessary for protein kinase C's high-affinity interaction with diacylglycerol-containing membranes. Biochemistry. 1994 May 31;33(21):6651–6658. doi: 10.1021/bi00187a035. [DOI] [PubMed] [Google Scholar]
  24. Rennick D., Hunte B., Holland G., Thompson-Snipes L. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts. Blood. 1995 Jan 1;85(1):57–65. [PubMed] [Google Scholar]
  25. SHORE P. A., BURKHALTER A., COHN V. H., Jr A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959 Nov;127:182–186. [PubMed] [Google Scholar]
  26. Saito H., Okajima F., Molski T. F., Sha'afi R. I., Ui M., Ishizaka T. Effects of ADP-ribosylation of GTP-binding protein by pertussis toxin on immunoglobulin E-dependent and -independent histamine release from mast cells and basophils. J Immunol. 1987 Jun 1;138(11):3927–3934. [PubMed] [Google Scholar]
  27. Sakane F., Yamada K., Imai S., Kanoh H. Porcine 80-kDa diacylglycerol kinase is a calcium-binding and calcium/phospholipid-dependent enzyme and undergoes calcium-dependent translocation. J Biol Chem. 1991 Apr 15;266(11):7096–7100. [PubMed] [Google Scholar]
  28. Sperr W. R., Czerwenka K., Mundigler G., Müller M. R., Semper H., Klappacher G., Glogar H. D., Lechner K., Valent P. Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. Int Arch Allergy Immunol. 1993;102(2):170–175. doi: 10.1159/000236568. [DOI] [PubMed] [Google Scholar]
  29. Stekhoven F. M., Tijmes J., Umeda M., Inoue K., De Pont J. J. Monoclonal antibody to phosphatidylserine inhibits Na+/K(+)-ATPase activity. Biochim Biophys Acta. 1994 Aug 24;1194(1):155–165. doi: 10.1016/0005-2736(94)90215-1. [DOI] [PubMed] [Google Scholar]
  30. Swieter M., Ghali W. A., Rimmer C., Befus D. Interferon-alpha/beta inhibits IgE-dependent histamine release from rat mast cells. Immunology. 1989 Apr;66(4):606–610. [PMC free article] [PubMed] [Google Scholar]
  31. Taylor A. M., Galli S. J., Coleman J. W. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology. 1995 Nov;86(3):427–433. [PMC free article] [PubMed] [Google Scholar]
  32. Tsai M., Chen R. H., Tam S. Y., Blenis J., Galli S. J. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur J Immunol. 1993 Dec;23(12):3286–3291. doi: 10.1002/eji.1830231234. [DOI] [PubMed] [Google Scholar]
  33. Tsai M., Shih L. S., Newlands G. F., Takeishi T., Langley K. E., Zsebo K. M., Miller H. R., Geissler E. N., Galli S. J. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med. 1991 Jul 1;174(1):125–131. doi: 10.1084/jem.174.1.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tsai M., Tam S. Y., Galli S. J. Distinct patterns of early response gene expression and proliferation in mouse mast cells stimulated by stem cell factor, interleukin-3, or IgE and antigen. Eur J Immunol. 1993 Apr;23(4):867–872. doi: 10.1002/eji.1830230415. [DOI] [PubMed] [Google Scholar]
  35. Valent P. The riddle of the mast cell: kit(CD117)-ligand as the missing link? Immunol Today. 1994 Mar;15(3):111–114. doi: 10.1016/0167-5699(94)90153-8. [DOI] [PubMed] [Google Scholar]
  36. White J. R., Pearce F. L. Characteristics of histamine secretion from rat peritoneal mast cells sensitized to the nematode Nippostrongylus brasiliensis. Immunology. 1982 Jun;46(2):353–359. [PMC free article] [PubMed] [Google Scholar]
  37. Wypych J., Bennett L. G., Schwartz M. G., Clogston C. L., Lu H. S., Broudy V. C., Bartley T. D., Parker V. P., Langley K. E. Soluble kit receptor in human serum. Blood. 1995 Jan 1;85(1):66–73. [PubMed] [Google Scholar]
  38. Ziegler I., Hültner L., Egger D., Kempkes B., Mailhammer R., Gillis S., Rödl W. In a concerted action kit ligand and interleukin 3 control the synthesis of serotonin in murine bone marrow-derived mast cells. Up-regulation of GTP cyclohydrolase I and tryptophan 5-monooxygenase activity by the kit ligand. J Biol Chem. 1993 Jun 15;268(17):12544–12551. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES